JPRN-jRCTs031220490招募中3 期
An open-label, single-arm study to develop a novel ophthalmic testing method in patients with cystinosis
Yamamoto Yuuka0 个研究点目标入组 6 人开始时间: 2022年12月5日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable(—)
- 性别
- All
入选标准
- •Patients with cystinosis who meet the following criteria
- •1) Patients with presence of corneal cystine crystal deposits assessed during ophthalmic examination
- •2) Patients who have ability to or intend to comply with the 4 times daily instillation regimen
- •3) Patients who are judged by the principal investigator or sub-investigator to be appropriate for inclusion in the study.
- •4) Patients who have given written consent to participate in the research in person.
- •5) Patients who are at least 18 years of age at the time consent is obtained
排除标准
- •1) Patients who are obviously suffering from a serious acute disease
- •2) Patients with a history of hypersensitivity to the active ingredients or additives of the test drug
- •3) Pregnant or possibly pregnant or lactating women
- •4) Persons who are judged by the principal investigator to be inappropriate for inclusion in the study
研究者
相似试验
招募中
Unknown
An open-label, single-arm study to investigate the efficacy of Favipiravir on Lassa Fever for Post Exposure Prophylaxisassa feverJPRN-jRCTs031230118Morioka Shinichiro5
进行中(未招募)
1 期
A study to understand disease biology and to test the effect and safety of inhaled nemiralisib in adult patients with APDSEUCTR2015-004876-31-GBGlaxoSmithKline Research & Development Ltd20
进行中(未招募)
3 期
A Japanese phase III multicenter, single-arm, open-label clinical trial to assess the efficacy and safety of the diagnosis/treatment of lymphedema by ICG fluorescent lymphangiography in patients with secondary lymphedemaJPRN-jRCT2031190064Akita Shinsuke50
已完成
1 期
A Clinical study on quadrivalent Human Papilloma virus vaccineCTRI/2017/02/007785Serum Institute of India Pvt Ltd47
已完成
1 期
A clinical study to assess safety and tolerability of tetanus, diptheria, and pertussis vaccine in adults.CTRI/2017/03/008003Serum Institute of India Pvt Ltd23
